Significant unprotected left main (LM) coronary artery disease is frequently associated with
severe multivessel disease and increased mortality and morbidity compared with non-LM …

Background Percutaneous coronary intervention (PCI) has emerged as an alternative
treatment to coronary artery bypass grafting (CABG) for unprotected left main (LM) coronary …

Abstract Purpose of Review To review the clinical evidence on the use of percutaneous
coronary intervention (PCI) revascularization options in left main (LM) disease in …

Background: Hemodynamically significant unprotected left main (LM) coronary artery
disease is a high-risk clinical condition because of the large area of myocardium at risk, and …

Left main coronary artery (LMCA) disease is the highest-risk lesion subset of ischemic heart
disease, and has traditionally been an indication for coronary artery bypass grafting (CABG) …

Introduction: There is clear evidence of a significant reduction in all major cardiovascular
adverse events (MACE) by coronary artery bypass grafting (CABG) in left main coronary …

Objective To evaluate the outcomes of patients with significant (≥ 50%) left main coronary
artery disease (LMCAD) undergoing medical treatment (MT) or coronary artery bypass …

Background—The clinical characteristics that identify high-risk subsets of patients with
unprotected left main coronary artery disease undergoing percutaneous coronary …

Objectives: This study sought to investigate long-term clinical outcomes following coronary
artery bypass graft (CABG) and percutaneous coronary intervention (PCI) in patients with …

Recent studies have suggested that percutaneous coronary intervention (PCI) in patients
with unprotected left main coronary artery (LMCA) disease renders outcomes comparable to …